Skip to main content
Retour
Watch Compare

Zivo Bioscience, Inc.

Qualité des données : 100%
Également cotée sous ZIVOW OTC
ZIVO
OTC Manufacturing Chemicals
3,25 €
▼ 0,35 € (-9,72%)
Cap. Boursière: 12,64 M
Prix
3,25 €
Cap. Boursière
12,64 M
Fourchette du Jour
3,00 € — 4,00 €
Fourchette 52 Semaines
3,00 € — 20,00 €
Volume
3 644
Ouverture 4,00 €
Moyenne 50J / 200J
9,03 €
64,00% below
Moyenne 50J / 200J
11,70 €
72,23% below

Quick Summary

Points Clés

Revenue grew 67,44% annually over 5 years — strong growth
Negative free cash flow of -3,08 M
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 401,17%

Croissance

Revenue Growth (5Y)
67,44%
Au-dessus de la moyenne du secteur (1,82%)
Revenue (1Y)468,61%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROICN/A
Net Margin-4059,73%
Op. Margin-4045,65%

Sécurité

Debt / Equity
N/A
Current Ratio0,08
Interest CoverageN/A

Valorisation

PE (TTM)
-1,49
En dessous de la moyenne du secteur (-1,48)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Manufacturing (1364 pairs)
Métrique Action Médiane du Secteur
P/E -1,5 -1,5
P/B — 1,6
ROE % — -53,4
Net Margin % -4059,7 -41,5
Rev Growth 5Y % 67,4 1,8
D/E — 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 468,61% Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 67,44% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 209 025,0 Net Income (TTM) -8,49 M
ROE N/A ROA -1344,00%
Gross Margin 31,68% Operating Margin -4045,65%
Net Margin -4059,73% Free Cash Flow (TTM) -3,08 M
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,08
Interest Coverage N/A Asset Turnover 0,33
Working Capital -3,33 M Tangible Book Value -3,29 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -1,49 Forward P/E N/A
P/B Ratio N/A P/S Ratio 60,46
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -24,36%
Market Cap 12,64 M Enterprise Value 12,64 M
Per Share
EPS (Diluted TTM) -6,05 Revenue / Share 0,05
FCF / Share -0,79 OCF / Share -0,79
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 36,28%
SBC-Adj. FCF N/A Growth Momentum 401,17

Income Statement

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Revenue 157 220,0 27 650,0 0,0 0,0 20 000,0
Net Income -13,38 M -7,78 M -8,75 M -9,16 M -9,11 M
EPS (Diluted) -4,23 — — — —
Gross Profit 48 952,0 11 610,0 — — —
Operating Income -13,36 M -7,26 M -8,73 M -9,05 M -8,56 M
EBITDA — — — — —
R&D Expenses 3,13 M 1,38 M 2,24 M 2,12 M 3,75 M
SG&A Expenses — — — — —
D&A — — — 0,0 0,0
Interest Expense — 23 793,0 13 319,0 44 677,0 —
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2024 FY2023 FY2022 FY2021 FY2020
Total Assets 1,64 M 555 715,0 2,12 M 8,99 M 220 179,0
Total Liabilities 2,16 M 2,76 M 2,13 M 2,95 M 11,53 M
Shareholders' Equity -514 897,0 -2,21 M -10 622,0 6,04 M -11,31 M
Total Debt — — — — —
Cash & Equivalents — — 1,80 M 8,90 M 137 862,0
Current Assets 1,64 M 425 377,0 1,90 M 8,96 M 167 815,0
Current Liabilities 2,04 M 2,76 M 2,03 M 2,95 M 11,39 M